Contract 36C26026F0059
Amneal Pharmaceuticals Of New York, Llc · Department Of Veterans Affairs · October 7, 2025
Amneal Pharmaceuticals Of New York, Llc was awarded a federal contract by Department Of Veterans Affairs on October 7, 2025 for $319,000 of work in pharmaceutical preparation manufacturing. Performance is in Brookhaven, NY. This is a task or delivery order issued under parent IDIQ 36F79722D0161. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 6, 2026.
Contract details
- PIID
- 36C26026F0059
- Parent IDIQ
- 36F79722D0161
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Brookhaven, NY
- First action
- October 7, 2025
- Latest action
- March 6, 2026
Description
PHARMACEUTICAL - XYREM (SODIUM OXYBATE) - 2026 PRICE INCREASE & DOSAGE USED.
Modification timeline
-
March 6, 2026Mod P00002 · Funding Only Action$319.4K
-
October 21, 2025Mod P00001 · Other Administrative ActionPHARMACEUTICAL - XYREM (SODIUM OXYBATE)$311.5K
-
October 7, 2025Base awardPHARMACEUTICAL - XYREM (SODIUM OXYBATE)$311.5K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36C26026F0059?
Contract 36C26026F0059 is a federal contract awarded to Amneal Pharmaceuticals Of New York, Llc by Department Of Veterans Affairs on October 7, 2025 for $319,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 36C26026F0059?
Amneal Pharmaceuticals Of New York, Llc won contract 36C26026F0059 from Department Of Veterans Affairs.
How much is contract 36C26026F0059 worth?
Contract 36C26026F0059 has obligated $319,000 to date.